Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 366

1.

The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.

Takacs M, Segesdi J, Banati F, Koroknai A, Wolf H, Niller HH, Minarovits J.

Mediterr J Hematol Infect Dis. 2009 Nov 15;1(2):e2009012. doi: 10.4084/MJHID.2009.012.

2.

Epigenetic regulation of latent Epstein-Barr virus promoters.

Takacs M, Banati F, Koroknai A, Segesdi J, Salamon D, Wolf H, Niller HH, Minarovits J.

Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):228-35. doi: 10.1016/j.bbagrm.2009.10.005. Epub 2009 Oct 22. Review.

PMID:
19853674
3.
4.

Epigenotypes of latent herpesvirus genomes.

Minarovits J.

Curr Top Microbiol Immunol. 2006;310:61-80. Review.

PMID:
16909907
5.

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.

Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS.

J Exp Med. 1993 Feb 1;177(2):339-49.

6.

The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.

Szenthe K, Koroknai A, Banati F, Bathori Z, Lozsa R, Burgyan J, Wolf H, Salamon D, Nagy K, Niller HH, Minarovits J.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):489-95. doi: 10.1016/j.bbrc.2013.03.022. Epub 2013 Mar 23.

PMID:
23528241
7.

Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.

Wang C, Zhou H, Xue Y, Liang J, Narita Y, Gerdt C, Zheng AY, Jiang R, Trudeau S, Peng CW, Gewurz BE, Zhao B.

J Virol. 2018 Apr 13;92(9). pii: e02155-17. doi: 10.1128/JVI.02155-17. Print 2018 May 1.

PMID:
29467311
8.
9.
10.

Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Owen TJ, O'Neil JD, Dawson CW, Hu C, Chen X, Yao Y, Wood VH, Mitchell LE, White RJ, Young LS, Arrand JR.

Mol Cancer. 2010 Sep 15;9:241. doi: 10.1186/1476-4598-9-241.

11.

Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.

Brink AA, Dukers DF, van den Brule AJ, Oudejans JJ, Middeldorp JM, Meijer CJ, Jiwa M.

J Clin Pathol. 1997 Nov;50(11):911-8.

12.

BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes.

Oudejans JJ, van den Brule AJ, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, Walboomers JM, Meijer CJ.

Blood. 1995 Sep 1;86(5):1893-902.

13.
14.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
15.

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.

Rowe M, Raithatha S, Shannon-Lowe C.

J Virol. 2014 Oct;88(20):12065-76. doi: 10.1128/JVI.01431-14. Epub 2014 Aug 13.

16.

[Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].

Wang Y, Luo B, Zhao P, Huang BH.

Ai Zheng. 2004 Jul;23(7):782-7. Chinese.

PMID:
15248912
17.

Epstein-Barr virus-host cell interactions: an epigenetic dialog?

Niller HH, Szenthe K, Minarovits J.

Front Genet. 2014 Oct 21;5:367. doi: 10.3389/fgene.2014.00367. eCollection 2014.

18.

High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Bakos A, Banati F, Koroknai A, Takacs M, Salamon D, Minarovits-Kormuta S, Schwarzmann F, Wolf H, Niller HH, Minarovits J.

Virus Genes. 2007 Oct;35(2):195-202. Epub 2007 May 18.

PMID:
17510783
19.

Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.

Niller HH, Banati F, Salamon D, Minarovits J.

Adv Exp Med Biol. 2016;879:39-69. doi: 10.1007/978-3-319-24738-0_3. Review.

PMID:
26659263

Supplemental Content

Support Center